CL
Chan Henry Lee (SVP, General Counsel) filed 15 Form 4 reports in the trailing twelve months (0 purchases, 15 sales), most often in BeOne Medicines AG (ONC). The largest single filing was $960K of ONC (2,666 sh × $360.00, as filed), executed Aug 11. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
15
0 buys · 15 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.2M
shares × price, as filed
Last traded
Sep 30
Filed Oct 2
Median ADV $130.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $15.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
15 filings
Sector per market data · by filing · past 12 months
Most traded names
ONCRecent filings
ONCSALE
BeOne Medicines AG
View filing →
$3.2M9,706 sh across 4 lots
Exec Sep 10 2025
Filed Sep 12 2025 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $3.3M
11,013 sh across 3 lots
Exec Aug 13 2025
Filed Aug 15 2025 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $280K
920 sh × $304.60
Exec Jul 30 2025
Filed Jul 31 2025 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $112K
422 sh × $266.50
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $120K
470 sh × $255.78
Exec Jun 6 2025
Filed Jun 10 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. View filing → $331K
1,205 sh × $275.00
Exec Feb 27 2025
Filed Mar 3 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. View filing → $284K
1,102 sh across 2 lots
Exec Feb 21 2025
Filed Feb 25 2025 · 5:30 PM ET